[Abstract Only] Study: Comparison of amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders
18 Oct, 2020 | 23:00h | UTCAmisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial – The Lancet Psychiatry (link to abstract – $ for full-text)
Commentary on Twitter
https://twitter.com/TheLancetPsych/status/1317014163823104000


